{"id":"https://openalex.org/W2065154758","doi":"https://doi.org/10.1007/bf02815133","title":"GM1 monosialoganglioside pretreatment protects against soman-induced seizure-related brain damage","display_name":"GM1 monosialoganglioside pretreatment protects against soman-induced seizure-related brain damage","publication_year":1998,"publication_date":"1998-05-01","ids":{"openalex":"https://openalex.org/W2065154758","doi":"https://doi.org/10.1007/bf02815133","mag":"2065154758","pmid":"https://pubmed.ncbi.nlm.nih.gov/9778643"},"language":"en","primary_location":{"id":"doi:10.1007/bf02815133","doi":"https://doi.org/10.1007/bf02815133","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf02815133","pdf_url":null,"source":{"id":"https://openalex.org/S177864979","display_name":"Molecular and Chemical Neuropathology","issn_l":"1044-7393","issn":["1044-7393","2168-8729"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular and Chemical Neuropathology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074943478","display_name":"Gerald P. H. Ballough","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald P. H. Ballough","raw_affiliation_strings":["Neurotoxicology Branch, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotoxicology Branch, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA","institution_ids":["https://openalex.org/I4210088792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079628051","display_name":"Frank J. Cann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank J. Cann","raw_affiliation_strings":["Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","institution_ids":[]},{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground","institution_ids":["https://openalex.org/I4210088792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102027809","display_name":"Catherine D. Morffy Smith","orcid":"https://orcid.org/0000-0001-8575-6453","observed_orcids":["https://orcid.org/0000-0001-8575-6453"]},"institutions":[{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine D. Smith","raw_affiliation_strings":["Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","institution_ids":[]},{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground","institution_ids":["https://openalex.org/I4210088792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113635363","display_name":"Jeffry S. Forster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffry S. Forster","raw_affiliation_strings":["Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","institution_ids":[]},{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground","institution_ids":["https://openalex.org/I4210088792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084445970","display_name":"Cathleen E. Kling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cathleen E. Kling","raw_affiliation_strings":["Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","institution_ids":[]},{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground","institution_ids":["https://openalex.org/I4210088792"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005034584","display_name":"Margaret G. Filbert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret G. Filbert","raw_affiliation_strings":["Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, 21010, Aberdeen Proving Ground, MD","institution_ids":[]},{"raw_affiliation_string":"Neurotoxicology Branch, Pharmacology Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground","institution_ids":["https://openalex.org/I4210088792"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210088792"],"apc_list":null,"apc_paid":null,"fwci":1.4582,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.80142332,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"34","issue":"1","first_page":"1","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10875","display_name":"Pesticide Exposure and Toxicity","score":0.6298999786376953,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10875","display_name":"Pesticide Exposure and Toxicity","score":0.6298999786376953,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.16300000250339508,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.05559999868273735,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soman","display_name":"soman","score":0.9679999947547913},{"id":"https://openalex.org/keywords/organophosphate-neurotoxicity","display_name":"organophosphate neurotoxicity","score":0.7289999723434448},{"id":"https://openalex.org/keywords/status-epilepticus","display_name":"status epilepticus","score":0.9629999995231628},{"id":"https://openalex.org/keywords/seizure-induced-brain-damage","display_name":"seizure-induced brain damage","score":0.8429999947547913},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9789999723434448},{"id":"https://openalex.org/keywords/acetylcholinesterase","display_name":"acetylcholinesterase","score":0.8100000023841858},{"id":"https://openalex.org/keywords/basolateral-amygdala","display_name":"basolateral amygdala","score":0.8840000033378601},{"id":"https://openalex.org/keywords/piriform-cortex","display_name":"piriform cortex","score":0.9419999718666077},{"id":"https://openalex.org/keywords/neuronal-necrosis","display_name":"neuronal necrosis","score":0.8119999766349792},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C2780266723","wikidata":"https://www.wikidata.org/wiki/Q408044","display_name":"Soman","level":4,"score":0.901607871055603},{"id":"https://openalex.org/C2781458332","wikidata":"https://www.wikidata.org/wiki/Q720026","display_name":"Brain damage","level":2,"score":0.6946729421615601},{"id":"https://openalex.org/C2777010014","wikidata":"https://www.wikidata.org/wiki/Q852376","display_name":"Convulsion","level":3,"score":0.5189473628997803},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5134400129318237},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.47228723764419556},{"id":"https://openalex.org/C2993744773","wikidata":"https://www.wikidata.org/wiki/Q2945973","display_name":"Neuronal damage","level":3,"score":0.4410470724105835},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.4317089021205902},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34922513365745544},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.28320276737213135},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.26883119344711304},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.22793424129486084},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20991018414497375},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.17131268978118896},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1281486451625824}],"mesh":[{"descriptor_ui":"D000110","descriptor_name":"Acetylcholinesterase","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001923","descriptor_name":"Brain Chemistry","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001925","descriptor_name":"Brain Damage, Chronic","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D001925","descriptor_name":"Brain Damage, Chronic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D003292","descriptor_name":"Convulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003292","descriptor_name":"Convulsants","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D004569","descriptor_name":"Electroencephalography","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005677","descriptor_name":"G(M1) Ganglioside","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005677","descriptor_name":"G(M1) Ganglioside","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005904","descriptor_name":"Glial Fibrillary Acidic Protein","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007091","descriptor_name":"Image Processing, Computer-Assisted","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007276","descriptor_name":"Injections, Intraventricular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008869","descriptor_name":"Microtubule-Associated Proteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D009498","descriptor_name":"Neurotoxins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009498","descriptor_name":"Neurotoxins","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012999","descriptor_name":"Soman","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012999","descriptor_name":"Soman","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D013226","descriptor_name":"Status Epilepticus","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D013226","descriptor_name":"Status Epilepticus","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D013226","descriptor_name":"Status Epilepticus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013226","descriptor_name":"Status Epilepticus","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf02815133","doi":"https://doi.org/10.1007/bf02815133","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf02815133","pdf_url":null,"source":{"id":"https://openalex.org/S177864979","display_name":"Molecular and Chemical Neuropathology","issn_l":"1044-7393","issn":["1044-7393","2168-8729"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular and Chemical Neuropathology","raw_type":"journal-article"},{"id":"pmid:9778643","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9778643","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular and chemical neuropathology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":68,"referenced_works":["https://openalex.org/W124166619","https://openalex.org/W131351383","https://openalex.org/W188541714","https://openalex.org/W249845531","https://openalex.org/W1195334433","https://openalex.org/W1519184577","https://openalex.org/W1824128596","https://openalex.org/W1866562900","https://openalex.org/W1970520842","https://openalex.org/W1974641269","https://openalex.org/W1981280975","https://openalex.org/W1983186077","https://openalex.org/W1985554234","https://openalex.org/W1985638448","https://openalex.org/W1986607212","https://openalex.org/W1997531101","https://openalex.org/W1998939554","https://openalex.org/W2002437982","https://openalex.org/W2013234943","https://openalex.org/W2013253000","https://openalex.org/W2015284998","https://openalex.org/W2016333981","https://openalex.org/W2021144835","https://openalex.org/W2023145582","https://openalex.org/W2025029225","https://openalex.org/W2028049923","https://openalex.org/W2031280774","https://openalex.org/W2033769657","https://openalex.org/W2039504576","https://openalex.org/W2041549148","https://openalex.org/W2043675793","https://openalex.org/W2044246036","https://openalex.org/W2046432329","https://openalex.org/W2051395367","https://openalex.org/W2052309765","https://openalex.org/W2053121988","https://openalex.org/W2055749276","https://openalex.org/W2058117427","https://openalex.org/W2065113439","https://openalex.org/W2065171993","https://openalex.org/W2072202911","https://openalex.org/W2072599718","https://openalex.org/W2079257658","https://openalex.org/W2080399942","https://openalex.org/W2082480382","https://openalex.org/W2087753104","https://openalex.org/W2088519488","https://openalex.org/W2094166598","https://openalex.org/W2095351701","https://openalex.org/W2096428903","https://openalex.org/W2119125561","https://openalex.org/W2119262129","https://openalex.org/W2122453698","https://openalex.org/W2152985670","https://openalex.org/W2163815564","https://openalex.org/W2217367186","https://openalex.org/W2222594107","https://openalex.org/W2224466666","https://openalex.org/W2233089481","https://openalex.org/W2320073138","https://openalex.org/W2401788416","https://openalex.org/W2402163933","https://openalex.org/W2408238734","https://openalex.org/W2412154598","https://openalex.org/W2414153186","https://openalex.org/W2418536964","https://openalex.org/W2772099086","https://openalex.org/W4233808246"],"related_works":["https://openalex.org/W2109265817","https://openalex.org/W2103309435","https://openalex.org/W1978921440","https://openalex.org/W2002880606","https://openalex.org/W2064240849","https://openalex.org/W2065350460","https://openalex.org/W7098144740","https://openalex.org/W2055749276","https://openalex.org/W2051636429","https://openalex.org/W254470748"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}